The evidence has been inconsistent regarding the impact of cancer-predisposing BRCA1 variants on prostate cancer but a subtler effect is probable, with an odds ratio of 1.35(17), and the relative risk increase is higher at younger ages(21, 22). This evidence concerns the gene BRCA1 and cancer.